TRPC3 and lung carcinoma: TRPC3, as a driver gene at both genomics and transcriptomics levels have also been recognized as a promising clinical biomarker for lung cancer (Lastraioli et al., 2015), indicating the clinical significance of such multi-omics biomarker.